Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an electrolyte that plays a crucial role in numerous biochemical functions, including nerve impulse transmission, muscle contraction, and enzyme activity. It is available for intravenous (IV) and intramuscular (IM) administration, as well as oral formulations (though less commonly used for acute management).
## Primary Indications
* Treatment of hypomagnesemia.
* Prevention and treatment of eclampsia in pregnant and postpartum patients.
* Management of torsades de pointes.
* Management of status asthmaticus (adjunctive therapy).
* Management of severe hypokalemia with hypomagnesemia.
## Adult Dosing
* **Hypomagnesemia:**
* **IV:** 1 to 4 grams (8 to 32 mEq) diluted in 1000 mL of IV fluid (e.g., D5W, NS) infused over 5 to 60 minutes. Follow with an infusion of 1 to 4 grams per hour as needed. Alternatively, 1 gram (8 mEq) can be administered IV push over 15-30 minutes for severe, symptomatic hypomagnesemia, but this carries a higher risk of hypotension and flushing.
* **IM:** 1 gram (8 mEq) every 4 hours as needed. Administer deep into the gluteal muscle, often split between two sites.
* **Eclampsia Prophylaxis/Treatment:** 4 to 5 grams (32 to 40 mEq) IV load over 5 minutes, followed by a continuous infusion of 1 to 2 grams per hour. IM loading dose of 5 grams (40 mEq) in each buttock (total 10 grams) may be used if IV access is difficult.
* **Torsades de Pointes:** 1 to 2 grams (8 to 16 mEq) diluted in 100 mL of IV fluid infused over 5 to 10 minutes. May repeat and follow with an infusion of 0.5 to 1 gram per hour.
* **Status Asthmaticus:** 2 grams (16 mEq) diluted in 100 mL of IV fluid infused over 15 to 30 minutes.
* **Severe Hypokalemia with Hypomagnesemia:** Dosing is complex and depends on serum potassium and magnesium levels. Often requires separate potassium repletion. A typical regimen might involve 2 to 4 grams (16 to 32 mEq) IV in divided doses, carefully monitoring both electrolytes.
## Pediatric Dosing
Dosing for pediatric patients is highly variable and depends on the indication, age, weight, and severity of deficiency. Dosing is often guided by local protocols or specialist recommendations.
* **Hypomagnesemia (IV):** Commonly cited doses range from 25 to 50 mg/kg per dose (e.g., 25 mg/kg of magnesium sulfate equivalent to approximately 2 mEq/kg) infused over 1 to 3 hours, not to exceed the adult maximum dose per day. Maintenance infusions may also be used.
* **Eclampsia (IV):** Similar to adults, but specific protocols exist (e.g., loading dose of 20-40 mg/kg, followed by maintenance infusion).
## Dose Adjustments
No specific dose adjustment for renal impairment is typically recommended for short-term IV use in hypomagnesemia, as magnesium is primarily eliminated by the kidneys. However, caution is advised in severe renal dysfunction, and serum magnesium levels should be closely monitored. Intravenous administration in patients with renal impairment may lead to hypermagnesemia.
## Contraindications
* Heart block.
* Hypermagnesemia.
* Myocardial infarction (in patients with normal magnesium levels).
* Hyperkalemia (relative contraindication, especially with renal impairment).
* Severe renal failure (use with caution).
## Adverse Effects
* **Common:** Flushing, sweating, hypotension, nausea, vomiting, drowsiness, lethargy.
* **Serious:** Respiratory depression, cardiac arrhythmias, loss of deep tendon reflexes, muscular weakness, hypermagnesemia (especially with renal impairment), hyperthermia.
## Key Drug Interactions
* **Calcium Salts:** May antagonize the effects of magnesium.
* **Neuromuscular Blocking Agents:** Magnesium can potentiate neuromuscular blockade.
* **Digitalis Glycosides:** Hypermagnesemia can increase the risk of digitalis toxicity.
* **Potassium-Sparing Diuretics:** May increase the risk of hypermagnesemia.
## Monitoring
* **Serum Magnesium Levels:** Monitor frequently, especially during IV infusions and in patients with renal impairment. Target levels vary by indication. For hypomagnesemia, target levels are typically 1.5 to 2.5 mEq/L (or 0.75 to 1.25 mmol/L). For eclampsia, therapeutic levels are generally considered 4 to 7 mEq/L (or 2 to 3.5 mmol/L).
* **Renal Function:** Assess baseline and monitor as clinically indicated.
* **Cardiac Rhythm:** Especially during rapid IV infusion or in patients with cardiac conditions.
* **Deep Tendon Reflexes:** Loss of reflexes can indicate rising magnesium levels.
* **Respiratory Rate:** Monitor for signs of respiratory depression.
* **Urine Output:** Adequate urine output is essential for magnesium excretion.
## Clinical Pearls
* Always dilute magnesium sulfate for IV infusion to prevent rapid administration, which can cause hypotension and cardiac arrest.
* IM injections can be painful; consider splitting doses or using a larger muscle group like the gluteus maximus.
* Monitor serum calcium levels if prolonged or high-dose magnesium therapy is administered.
* In pregnant patients with eclampsia, monitor fetal heart rate.
* The antidote for magnesium sulfate overdose is intravenous calcium gluconate.
***
*Disclaimer: This information is intended for clinical pharmacy professionals and should not be a substitute for professional medical advice. Always verify current prescribing information and consult with a healthcare provider or pharmacist for specific patient care decisions.*
